Odomzo (sonidegib)

100 % legal and regulated
Secured logistics globally
24/7 track & trace delivery
Safe payment by bank transfer or credit card

We are registered as an independent intermediary for medicines with the Dutch Ministry of Health

Odomzo (sonidegib)

How to buy Odomzo: You can order Odomzo (sonidegib) via TheSocialMedwork if the drug has not been approved and/or is not available in the patient's country. TheSocialMedwork - helping patients and doctors access the latest approved medicines and at the lowest price possible worldwide.

Manufacturer Eli Lilly and Co.
Disease Skin Cancer
Indication Locally advanced basal cell carcinoma
Mode of Action Hedgehog pathway inhibitor
Approval Status EMA approved (EU); FDA approved (USA); TGA approved (AUS)
Strength 200 mg

Who is sonidegib for?

Odomzo (sonidegib) is indicated for the treatment of patients with basal cell carcinoma which is locally advanced and which cannot be treated either by surgery or by radiotherapy [1][2][3].

Recommended dose

Complete information about Odomzo (sonidegib) dosage and administration can be found here: [3][4][2].
The standard dosage is:
  • One 200 mg capsule once a day at least 1 hour before and 2 hours after a meal.
Consult your treating doctor for personalised dosing.

What is sonidegib and how does it work?

Odomzo is a Hedgehog pathway inhibitor used to treat adults with locally advanced basal cell carcinoma (BCC) that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation therapy [3][4].
The Hedgehog signaling pathway is a set of processes that control a number of cell activities including cell growth and correct development and differentiation. The active ingredient in Odomzo, sonidegib,  attaches to a protein that controls the Hedgehog signaling pathway. By attaching to this protein, sonidegib blocks the Hedgehog signaling pathway and thereby reduces the growth and spread of cancer cells [1].
The most common side effects are muscle spasms, hair loss, taste disturbance, tiredness, nausea, vomiting, muscle and bone pain, belly ache, headache, diarrhoea, weight loss, loss of appetite, and itching. Women who are pregnant or who are breastfeeding must not take Odomzo [1].

What is sonidegibf's approval status?

Odomzo (sonidegib) was approved by:
  • FDA (USA) on July 24, 2015 [3]
  • EMA (EU) on August 14, 2015 [1]
  • TGA (AUS) on December 19, 2016 [2]
for the treatment of adults with locally advanced basal cell carcinoma (BCC) that cannot be treated with surgery or radiation therapy.
The approvals of Odomzo (sonidegib) for locally advanced BCC were based on one main study involving 230 patients with basal cell carcinoma which was either locally advanced or metastatic. Patients were started on two different doses of sonidegib: 200 or 800 mg once a day. The response on metastatic BCC was less than 20 %. However, the medicine resulted effective on patients with locally advanced BCC with a response rate of 56 % (95 % CI: 43.3, 68.3) on the 200 mg dose, with 5 % complete responses, and 45 % (95 % CI: 43.3, 68.3) [4] on the 800 mg dose [1]. On the 200 mg dosage, the time to tumour response was 4.0 months (95 % CI: 3.8, 5.6) and the median duration of response was 26.1 months [4].
[1] EMA. Human Medicines: Odomzo (sonidegib), 02/09/2015 (last update: 06/06/2017), cited on 22/05/2017.
[2] TGA. Public Summary. Odomzo (sonidegib), 10/08/2015.
[3] Summary of Product Characteristics [FDA]: Odomzo (sonidegib), Novartis Pharmaceuticals Corporation, Jul. 2015.
[4] Summary of Product Characteristics [EMA]: Odomzo (sonidegib), Sun Pharmaceutical Industries Europe B.V., Jun. 2017.

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Medicine information contained herein may be time sensitive. The absence of a warning for a given medicine or combination thereof in no way should be construed to indicate that the medicine or combination is safe, effective or appropriate for any given patient. Always consult your treating physician before starting a course of treatment.

How can we help?

★ ★ ★ ★ ★

We've received requests for support from patients and doctors in over 120 countries, and delivered medicines to 6 continents. They've given us a 5 star rating for our service. Read what our friends from around the world are saying...

"My experience has been excellent. TheSocialMedwork were totally knowledgeable about the medicine I was looking for, and how to get it delivered to me quickly and easily. I UNCONDITIONALLY recommend TSM to anyone, it is truly a world-class organisation."

— Charles, USA

"During the transaction process I was very well informed by TheSocialMedwork team. They have put so much effort to ensure the best service was offered to me. Moreover the medicine I ordered was imported two weeks earlier. I highly recommend TheSocialMedwork."

— Tomasz, Poland

"I hope you know how needed you are and what it means to get a prompt, succinct and helpful reply. You are our hero. You have given us realistic hope in obtaining needed drugs in a timely way."

— Regina, US

"TheSocialMedwork were so helpful in getting the right medication to me, expediting its delivery, and keeping in touch. They simply can't do enough to help you. I would not hesitate to recommend TheSocialMedwork to anybody. Lovely people."

— Stephen, UK

"Totally awesome! Keep up the great work you're doing!"

— Dee, Australia

"When the doctor tells you that there are no treatments left to try, search further - there may be new treatments in other countries."

— Charlotte, The Netherlands

"TheSocialMedwork's professional capabilities, kindness and patience deserve our gratitude and respect."

— Haoyu, China

"My daughter died at the age of 21 because she couldn't get the treatment that might have saved her life. Now TheSocialMedwork might be able to help people like Abigail to get the best treatment."

— Frank, Virginia, USA

"The team is highly professional, friendly and will take care of everything. More options for doctor and patients. This service is transparent, unique and necessary. Keep it up!"

— Pa Tric, Germany

"Excellent communication and clarifications given every time when requested. They also provide fantastic support and updates from the start till the end of the process of the medicine provisioning."

— Milos, Serbia & Montenegro

Registered with the Dutch Ministry of Health as an independent intermediary, Registration number 6730 BEM
Registered as a USA Delaware LLC.

Our service uses cookies.